Posted:
#1
Anybody have thoughts on ACUS? Looking to pick up a few hundred shares and see what happens. The risk/reward at this level seems reasonable to me.
Thanks.
Thoughts on ACUS
Views: 907
Posts: 20
Posted:
#5
Take a look at the following article from MSN dated August 17th, research by Zach’s; it’s what drew my attention to this stock. I don’t believe the initial Phase III trails were totally successful, so I’ve held off buying. I may throw $500 at it with a stop/loss and see what happens. The nice thing about Imagify is there is no radioactivity, so less overall expense to hospitals.
https://news.moneycentral.msn.com/ticker/article.aspx?Feed=BW&Date=20070813&ID=7316413&Symbol=ACUS
It's been a little less than four months since the RAMP-2 data came out, and Acusphere ACUS shares are down 65% since then. Wall Street clearly thinks the company's drug Imagify has little chance for approval. In the meantime, cash burn is a concern and management is going to have to figure out how to raise money yet again in 2008. As a result, the Street views ACUS like a sinking ship.
With all that said, the opinion of medical and echo-cardiology community couldn't be more different from that of Wall Street. Cardiologists are excited about the data and the clear majority expects the use the drug immediately upon approval. Why is there such a split opinion, and who is right?
It is clear to us that this drug works, and is an extremely useful tool in the diagnosis of coronary artery disease (CAD). Looking at the tapes we quickly forgot about the botched trial endpoints, the dilutive offerings, and the mismanaged expectations of Wall Street. What we saw was powerful - a drug that really does do what it says, regardless of the statistical rigmarole.
Posted:
#7
Not sure. I think what they are saying is "we are burning through what's left of our cash and need to form a partnership with someone that has a stronger balance sheet than us to continue operations". It may be OK if a major player steps up.
Let's see what happens in the morning. I didn't see any after hours trades, but I could be wrong.
Posted:
#14
Think I saw on CNBC wire this morning that the FDA has issued a warning on the use of enhancement agents during ultrasounds, or in otherwords, Acusphere's Imagify. I'm not in very deep into this and went in with my eyes wide open. So whatever happens, happens. Gonna ride this out, but I think I'm F'ed.
Posted:
#20
HOLY CRAP!!! My ACUS thread lives. LOL.
I've been really busy the past few weeks and my time on Covers has been limited. I saw someone was asking about ACUS in the main thread a few days ago, but I haven't had a chance to respond. Anyway, for whatever it's worth, I'm still holding, I have averaged my pps down to 98 cents 
Not sure what I can offer to anyone interested in this ticker. I guess I could put you to sleep telling you about their weak financial position, potential delisting in June, black box warnings even if Imagify is approved, delays in filing the NDA, stockholder approval for up to a 20:1 reverse split, or the fact that no one has seen the pier reviewed papers yet.
I'll tell you the science is great, but management to this point sucks balls. I'm done averaging my pps down any further at this point until they show me something meaningful.
If anyone has any specific questions on ACUS, I will try to help. In the meantime, I would encourage those people to visit the Yahoo forum on ACUS. It's about the only Yahoo forum I goto, There are several very knowledgable people there who truly understand the science and have been involved with NDA's in the past, so it's been very helpful for me.
Cheers all !!!
Hot Forum Topics
